US FDA Biosimilar Standards Likely Sealed Interchangeability Designation’s Fate

 
• By Derrick Gingery
  
FDA standards for biosimilar and interchangeable products largely are the same. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Interviews